- $1.50bn
- $1.28bn
- $271.83m
- 82
- 17
- 89
- 67
Annual income statement for Avepoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 116 | 152 | 192 | 232 | 272 |
| Cost of Revenue | |||||
| Gross Profit | 79.7 | 111 | 139 | 166 | 194 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 135 | 167 | 245 | 273 | 287 |
| Operating Profit | -19 | -15.4 | -53.5 | -41.1 | -15.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.6 | -15.9 | -32.8 | -33.6 | -18.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -20.2 | -17 | -33.2 | -38.7 | -21.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -20.2 | -17 | -35.2 | -41.6 | -21.7 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -128 | -51.4 | -68.1 | -41.6 | -21.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.708 | -0.285 | -0.481 | -0.229 | -0.119 |
| Dividends per Share |